SAFETY OUTCOMES OF ORAL ANTICOAGULANT THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION AND CHRONIC KIDNEY DISEASE

被引：0
|
作者：
Igamberdieva, Ranokhon [1 ]
Abdullaev, Sherzod [2 ]
机构：
[1] Tashkent Pediat Med Inst, Internal Med, Nephrol & Hemodialysis, Asian Origins Asia East Asia Southeast Asia, Tashkent, Uzbekistan
[2] Republican Sci & Pract Med Ctr Nephrol & Kidney T, Immunogenet, Asian Origins Asia East Asia Southeast Asia, Tashkent, Uzbekistan
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
3896
引用
收藏
页码：I141 / I141
页数：1
相关论文
共 50 条
  • [21] Direct oral anticoagulants in patients with atrial fibrillation and chronic kidney disease
    Ozbek, Kerem
    Cicekcioglu, Huelya
    Cetin, Mustafa
    Duyuler, Pinar Turker
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2020, 43 (02): : 266 - 266
  • [22] Oral anticoagulation with coumarins for patients with atrial fibrillation and chronic kidney disease?
    Walter H. Hörl
    Wiener klinische Wochenschrift, 2009, 121 : 668 - 672
  • [23] Oral anticoagulation with coumarins for patients with atrial fibrillation and chronic kidney disease?
    Hoerl, Walter H.
    WIENER KLINISCHE WOCHENSCHRIFT, 2009, 121 (21-22) : 668 - 672
  • [24] The Quandary of Oral Anticoagulation in Patients With Atrial Fibrillation and Chronic Kidney Disease
    Schwartzenberg, Shmuel
    Lev, Eli I.
    Sagie, Alexander
    Korzets, Asher
    Kornowski, Ran
    AMERICAN JOURNAL OF CARDIOLOGY, 2016, 117 (03): : 477 - 482
  • [25] Novel oral anticoagulants in patients with chronic kidney disease and atrial fibrillation
    Stamellou, Eleni
    Floege, Juergen
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 (10) : 1683 - 1689
  • [26] Atrial Fibrillation and Anticoagulant Therapy in Patients with Chronic Obstructive Pulmonary Disease.
    Lainscak, M.
    Sarc, I.
    Ziherl, K.
    Jeric, T.
    Kosnik, M.
    Suskovic, S.
    Anker, S. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [27] Safety and Efficacy of Atrial Fibrillation Ablation in Patients With Chronic Kidney Disease
    Abualsuod, Amjad
    Habash, Fuad
    Khaled, Khaldia
    Gheith, Zaid
    Alqam, Bilal
    Madmani, Mohammed Eid
    Vallurupalli, Srikanth
    Maskoun, Waddah
    CIRCULATION, 2019, 140
  • [28] USEFULNESS OF ANTICOAGULANT THERAPY FOR ATRIAL FIBRILLATION IN CHRONIC KIDNEY DISEASE PATIENTS AFTER PERCUTANEOUS CORONARY INTERVENTION WITH STENTING
    Iwasaki, Yusuke
    Yamada, Takahisa
    Okuyama, Yuji
    Morita, Takashi
    Furukawa, Yoshio
    Tanaka, Koji
    Yasui, Taku
    Ueda, Hiromichi
    Okada, Takeshi
    Kawasaki, Masato
    Kuramoto, Yuki
    Fukunami, Masatake
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [29] Safety and Efficacy of Direct Oral Anticoagulants Versus Warfarin in Patients With Chronic Kidney Disease and Atrial Fibrillation
    Makani, Amber
    Saba, Samir
    Jain, Sandeep K.
    Bhonsale, Aditya
    Sharbaugh, Michael S.
    Thoma, Floyd
    Wang, Yisi
    Marroquin, Oscar C.
    Lee, Joon S.
    Estes, N. A. Mark
    Mulukutla, Suresh R.
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 125 (02): : 210 - 214
  • [30] Nationwide Frequency and Outcomes of Atrial Fibrillation in Patients with Chronic Kidney Disease
    Hebbar, P.
    Deshmukh, A.
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2011, 22 (04) : 493 - 494
12345